🔎 Trials Near Me

Почетна › Кронова болест › Пенсилванија › Philadelphia

Kliničke studije za Кронова болест u gradu Philadelphia, PA

11 studija za Кронова болест traži učesnike na lokacijama u gradu Philadelphia i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Тражи се учесникФаза 3
  • Thomas Jefferson University Hospital ( Site 5133), Philadelphia
Узраст од 16 до 80 · Оба пола · Ажурирано 10. 11. 2026. · NCT06430801

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Тражи се учесникФаза 3
  • Thomas Jefferson University - Medicine/GI and Hepatology, Philadelphia
Узраст од 18 до 70 · Оба пола · Ажурирано 4. 11. 2026. · NCT06937099

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

Тражи се учесникФаза 2/3
  • University of Pennsylvania, Philadelphia
  • Jefferson Digestive Health Institute, Philadelphia
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07196722

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

Тражи се учесникФаза 3
  • Children's Hospital of Philadelphia, Philadelphia
Узраст од 2 до 17 · Оба пола · Ажурирано 3. 11. 2026. · NCT05923073

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Тражи се учесникФаза 3
  • University of Pennsylvania School of Medicine-Site Number: 8400072, Philadelphia
Узраст од 16 до 80 · Оба пола · Ажурирано 21. 10. 2026. · NCT07184944

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Тражи се учесникФаза 3
  • University of Pennsylvania School of Medicine-Site Number: 8400072, Philadelphia
Узраст од 16 до 80 · Оба пола · Ажурирано 21. 10. 2026. · NCT07184931

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

Тражи се учесникФаза 3
  • Children's Hospital of Philadelphia (CHOP), Philadelphia
Узраст од 2 до 19 · Оба пола · Ажурирано 7. 10. 2026. · NCT04844606

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

Тражи се учесникФаза 3
  • Children's Hospital of Philadelphia, Philadelphia
Узраст од 2 до 17 · Оба пола · Ажурирано 7. 10. 2026. · NCT05509777

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Тражи се учесникФаза 2
  • University of Pennsylvania - Perelman Center for Advanced Medicine /ID# 265904, Philadelphia
Узраст од 18 до 75 · Оба пола · Ажурирано 25. 9. 2026. · NCT06548542

Precise Infliximab Exposure and Pharmacodynamic Control

Тражи се учесникФаза 2/3
  • Nemours Children's Health System-Wilmington, Wilmington · 25 ми удаљено
Узраст од 6 до 22 · Оба пола · Ажурирано 5. 5. 2026. · NCT05660746

Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial

Тражи се учесник
  • Children's Hospital of Philadelphia, Philadelphia
Узраст од 8 до 21 · Оба пола · Ажурирано 12. 6. 2025. · NCT06216899

Studije za Кронова болест u drugim gradovima

Ostale studije u gradu Philadelphia

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.